Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

D’Andrea’s disease (angiomegaly): a currently well-defined nosological entitys.

Taurone S, Spoletini M, Di Matteo FM, Mele R, Tromba L, Grippaudo FR, Minni A, Artico M.

J Biol Regul Homeost Agents. 2017 Apr-Jun;31(2):473-479.

PMID:
28685555
2.

Tyrosine phosphatase-related islet antigen 2(256-760) autoantibodies, the only marker of islet autoimmunity that increases by increasing the degree of BMI in obese subjects with type 2 diabetes.

Buzzetti R, Spoletini M, Zampetti S, Campagna G, Marandola L, Panimolle F, Dotta F, Tiberti C; NIRAD Study Group (NIRAD 8).

Diabetes Care. 2015 Mar;38(3):513-20. doi: 10.2337/dc14-1638. Epub 2015 Jan 7.

PMID:
25567348
3.

High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7).

Zampetti S, Campagna G, Tiberti C, Songini M, Arpi ML, De Simone G, Cossu E, Cocco L, Osborn J, Bosi E, Giorgino F, Spoletini M, Buzzetti R; NIRAD Study Group.

Eur J Endocrinol. 2014 Dec;171(6):697-704. doi: 10.1530/EJE-14-0342. Epub 2014 Sep 11.

PMID:
25213702
4.

Temporal trends of HLA, CTLA-4 and PTPN22 genotype frequencies among type 1 diabetes in Continental Italy.

Spoletini M, Zampetti S, Campagna G, Marandola L, Capizzi M, Buzzetti R; IMDIAB Study Group.

PLoS One. 2013 Apr 17;8(4):e61331. doi: 10.1371/journal.pone.0061331. Print 2013.

PMID:
23613833
5.

HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus.

Strollo R, Rizzo P, Spoletini M, Landy R, Hughes C, Ponchel F, Napoli N, Palermo A, Buzzetti R, Pozzilli P, Nissim A.

Diabetologia. 2013 Mar;56(3):563-72. doi: 10.1007/s00125-012-2780-1. Epub 2012 Nov 19.

PMID:
23160643
6.

[Childhhood obesity, insulin resistance and increased cardiovascular risk].

Carlone A, Venditti C, Cipolloni L, Zampetti S, Spoletini M, Capizzi M, Leto G, Buzzetti R.

Recenti Prog Med. 2012 Oct;103(10):369-72. doi: 10.1701/1171.12979. Italian.

PMID:
23114400
7.

GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD study 6).

Zampetti S, Capizzi M, Spoletini M, Campagna G, Leto G, Cipolloni L, Tiberti C, Bosi E, Falorni A, Buzzetti R; NIRAD Study Group.

J Clin Endocrinol Metab. 2012 Oct;97(10):3759-65. doi: 10.1210/jc.2012-2037. Epub 2012 Aug 3.

PMID:
22865904
8.

Emerging effects of early environmental factors over genetic background for type 1 diabetes susceptibility: evidence from a Nationwide Italian Twin Study.

Nisticò L, Iafusco D, Galderisi A, Fagnani C, Cotichini R, Toccaceli V, Stazi MA; Study Group on Diabetes of the Italian Society of Pediatric Endocrinology and Diabetology.

J Clin Endocrinol Metab. 2012 Aug;97(8):E1483-91. Epub 2012 May 8.

PMID:
22569240
9.

C-peptide response and HLA genotypes in subjects with recent-onset type 1 diabetes after immunotherapy with DiaPep277: an exploratory study.

Buzzetti R, Cernea S, Petrone A, Capizzi M, Spoletini M, Zampetti S, Guglielmi C, Venditti C, Pozzilli P; DiaPep Trialists Group.

Diabetes. 2011 Nov;60(11):3067-72. doi: 10.2337/db10-0560. Epub 2011 Sep 6.

PMID:
21896927
10.

Wrist circumference is a clinical marker of insulin resistance in overweight and obese children and adolescents.

Capizzi M, Leto G, Petrone A, Zampetti S, Papa RE, Osimani M, Spoletini M, Lenzi A, Osborn J, Mastantuono M, Vania A, Buzzetti R.

Circulation. 2011 Apr 26;123(16):1757-62. doi: 10.1161/CIRCULATIONAHA.110.012898. Epub 2011 Apr 11.

PMID:
21482965
11.

HLA-DRB1*03 and DRB1*04 are associated with atrophic gastritis in an Italian population.

Lahner E, Spoletini M, Buzzetti R, Corleto VD, Vannella L, Petrone A, Annibale B.

Dig Liver Dis. 2010 Dec;42(12):854-9. doi: 10.1016/j.dld.2010.04.011. Epub 2010 Jun 2.

PMID:
20627832
12.

Association of TCF7L2 gene variants with low GAD autoantibody titre in LADA subjects (NIRAD Study 5).

Zampetti S, Spoletini M, Petrone A, Capizzi M, Arpi ML, Tiberti C, Di Pietro S, Bosi E, Pozzilli P, Giorgino F, Buzzetti R; Nirad Study Group.

Diabet Med. 2010 Jun;27(6):701-4. doi: 10.1111/j.1464-5491.2010.02997.x.

PMID:
20546291
13.

Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4.

Lampasona V, Petrone A, Tiberti C, Capizzi M, Spoletini M, di Pietro S, Songini M, Bonicchio S, Giorgino F, Bonifacio E, Bosi E, Buzzetti R; Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study Group.

Diabetes Care. 2010 Jan;33(1):104-8. doi: 10.2337/dc08-2305. Epub 2009 Oct 6.

PMID:
19808923
14.

Identification of sequence variants in the UBL5 (ubiquitin-like 5 or BEACON) gene in obese children by PCR-SSCP: no evidence for association with obesity.

Sentinelli F, Romeo S, Cambuli VM, Cossu E, Cavallo MG, Zavarella S, Spoletini M, Buzzetti R, Baroni MG.

J Pediatr Endocrinol Metab. 2008 Dec;21(12):1139-45.

PMID:
19189687
15.

The PTPN22 1858T gene variant in type 1 diabetes is associated with reduced residual beta-cell function and worse metabolic control.

Petrone A, Spoletini M, Zampetti S, Capizzi M, Zavarella S, Osborn J, Pozzilli P, Buzzetti R; Immunotherapy Diabetes (IMDIAB) Group.

Diabetes Care. 2008 Jun;31(6):1214-8. doi: 10.2337/dc07-1158. Epub 2008 Feb 5.

PMID:
18252906
16.

A new variation in the promoter region, the -604 C>T, and the Leu72Met polymorphism of the ghrelin gene are associated with protection to insulin resistance.

Zavarella S, Petrone A, Zampetti S, Gueorguiev M, Spoletini M, Mein CA, Leto G, Korbonits M, Buzzetti R.

Int J Obes (Lond). 2008 Apr;32(4):663-8. Epub 2007 Dec 11.

PMID:
18071345
17.

Low-risk HLA genotype in Type 1 diabetes is associated with less destruction of pancreatic B-cells 12 months after diagnosis.

Spoletini M, Petrone A, Zampetti S, Capizzi M, Zavarella S, Osborn J, Foffi C, Tuccinardi D, Pozzilli P, Buzzetti R; IMDIAB Group.

Diabet Med. 2007 Dec;24(12):1487-90. Epub 2007 Oct 29.

PMID:
17971177
18.

The promoter region of the adiponectin gene is a determinant in modulating insulin sensitivity in childhood obesity.

Petrone A, Zavarella S, Caiazzo A, Leto G, Spoletini M, Potenziani S, Osborn J, Vania A, Buzzetti R.

Obesity (Silver Spring). 2006 Sep;14(9):1498-504.

PMID:
17030959
19.

The glucose clamp reveals an association between adiponectin gene polymorphisms and insulin sensitivity in obese subjects.

Buzzetti R, Petrone A, Zavarella S, Zampetti S, Spoletini M, Potenziani S, Leto G, Osborn J, Leonetti F.

Int J Obes (Lond). 2007 Mar;31(3):424-8. Epub 2006 Jun 27.

PMID:
16801926
20.

Residual insulin secretion at diagnosis of type 1 diabetes is independently associated with both, age of onset and HLA genotype.

Petrone A, Galgani A, Spoletini M, Alemanno I, Di Cola S, Bassotti G, Picardi A, Manfrini S, Osborn J, Pozzilli P, Buzzetti R.

Diabetes Metab Res Rev. 2005 May-Jun;21(3):271-5.

PMID:
15786423

Supplemental Content

Loading ...
Support Center